期刊文献+

Humanin及其衍生肽保护作用的研究进展 被引量:1

Advances in research on the protective effects of humanin and its derived peptides
原文传递
导出
摘要 Humanin(HN)是一种新发现的由24个氨基酸残基组成的短肽,在保护神经元免受阿尔茨海默病相关蛋白质诱导的损伤中发挥着重要作用。HN结构域中氨基酸残基的互相替换或延伸可形成多种衍生肽,部分具有更强的活性。虽然先前关于HN及其衍生肽的研究主要集中在阿尔茨海默病上,但是最近发现HN及其衍生肽具有更广泛的保护作用,涉及多个系统。现以HN为入手点,对近些年来HN及其衍生肽保护作用的研究进展进行综述,以期能为HN及其衍生肽的功能及疾病治疗的相关研究提供一定的参考。 Humanin(HN)is a newly discovered short peptide consisting of twenty four amino acid residues that plays an important role in protecting neurons from the damage induced by Alzheimer’s disease-related protein.The mutual substitution or extension of amino acid residues in the HN domain can form a plurality of derivative peptides,and some of which have stronger activity.Despite the previous studies on HN and its derived peptides have mainly focused on Alzheimer’s disease,it has recently been discovered that HN and its derived peptides have broader protection and involve multiple systems.This review will use HN as a starting point to review the research progress of the protective effects of HN and its derived peptides in recent years,in order to provide a reference for the related study of the function of HN and its derived peptides and the treatment of the diseases.
作者 殷博凯 郭艳芹 何治 YIN Bo-Kai;GUO Yan-Qin;HE Zhi(Medical College of Three Gorges University,Yichang 443002,China)
机构地区 三峡大学医学院
出处 《生命科学》 CSCD 北大核心 2019年第9期940-944,共5页 Chinese Bulletin of Life Sciences
基金 国家自然科学基金面上项目(81371318) 国家自然科学基金青年基金项目(81100873)
关键词 HUMANIN 衍生肽 保护作用 humanin derived peptides protective effects
  • 相关文献

参考文献2

二级参考文献59

  • 1Alonso AD, Grundke-lqbal I, Barra HS Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule- associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A 1997, 94: 298-303.
  • 2Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci 2005, 25, 10637-10647.
  • 3Terry RD. Cell death or synaptic loss in Alzheimer disease. J Neuropathol Exp Neurol 2000, 59: 1118-1119.
  • 4Paulson JB, Ramsden M, Forster C, Sherman MA, McGowan E, Ashe KH. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease. Am J Pathol 2008, 173: 762-772.
  • 5Mount C, Downton C. Alzheimer disease: progress or profit? Nat Med 2006, 12: 780-784.
  • 6Hardy J, Selkoe DJ. The amyioid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297: 353-356.
  • 7Sisodia SS, St GP. gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in? Nat Rev Neurosci 2002, 3: 281-290.
  • 8Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P3011 tau transgenic mice induced by Abeta 42 fibrils. Science 2001,293: 1491-1495.
  • 9Lippa CF, Nee LE, Mori H, St GP. Abeta-42 deposition precedes other changes in PS-1 Alzheimer's disease. Lancet 1998, 352: 1117-1118.
  • 10Roher AE, Lowenson JD, Clarke S, Woods AS, Cotter R J, Gowing E, et al. beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. Proc Natl Acad Sci U S A 1993, 90: 10836-10840.

共引文献8

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部